Asymchem: your CDMO today, with the capabilities of tomorrow

Published: 6-Oct-2023

Located at stand 3N10, the company is set to drive smarter, greener and more cost-effective manufacturing at CPHI

Founded in 1999, Asymchem is a global integrated CDMO providing drug R&D and manufacturing for leading pharmaceutical and biotech companies. The company's mission is to drive smarter, greener and more cost-effective manufacturing to support clinical research and commercialisation. 

Asymchem currently operates eight manufacturing facilities offering solutions ranging from early clinical stage to commercial stage, including R&D, cGMP production of advanced intermediates, APIs, formulations and clinical research services.

The company's scientists excel in the creation and manufacture of enzymes for use in bio-catalysis, the development of practical continuous flow technologies for commercialisation, and innovative research and process development from preclinical research to commercialisation for both non-GMP or GMP products. The work has frequently won them “most valuable partner” and “strategic partner” recognition from major pharma and leading biotech companies. For more information, please visit

Relevant companies

You may also like